Familial progressive supranuclear palsy: A literature review

Shinsuke Fujioka, Jay A Van Gerpen, Ryan J. Uitti, Dennis W Dickson, Zbigniew K Wszolek

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Many genes/loci associated with Parkinsonian disorders have been identified. However, the genetic causes for a number of familial forms of Parkinsonian disorders remain to be elucidated. Objective: It was the aim of this paper to review the familial progressive supranuclear palsy (PSP) cases without any known gene mutations published in the English literature. Methods: We searched the PubMed database for reports of familial PSP cases without known mutations. Results: We found 19 PSP families. The mean age at onset was approximately 60 years, and the mean disease duration was about 8 years. Parkinsonism and ophthalmoplegia were most frequently reported, and a vast majority of patients manifested with these two symptoms. Other symptoms such as falls, postural instability and pyramidal signs were also common. A small subset of patients transiently responded to L-dopa therapy. Conclusion: There is an increasing number of reported familial PSP. A recently performed genome-wide association study indicated genetic factors for this condition. Furthermore, clinical, pathological and genetic investigations will open new avenues to the discovery of causative genes and new therapeutics for PSP.

Original languageEnglish (US)
Pages (from-to)180-182
Number of pages3
JournalNeurodegenerative Diseases
Volume13
Issue number2-3
DOIs
StatePublished - Jan 2014

Fingerprint

Parkinsonian Disorders
Progressive Supranuclear Palsy
Literature
Ophthalmoplegia
Mutation
Genome-Wide Association Study
Genetic Association Studies
Levodopa
Age of Onset
PubMed
Genes
Databases
Therapeutics
Familial progressive supranuclear palsy

Keywords

  • Familial progressive supranuclear palsy
  • MAPT

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Familial progressive supranuclear palsy : A literature review. / Fujioka, Shinsuke; Van Gerpen, Jay A; Uitti, Ryan J.; Dickson, Dennis W; Wszolek, Zbigniew K.

In: Neurodegenerative Diseases, Vol. 13, No. 2-3, 01.2014, p. 180-182.

Research output: Contribution to journalArticle

Fujioka, Shinsuke ; Van Gerpen, Jay A ; Uitti, Ryan J. ; Dickson, Dennis W ; Wszolek, Zbigniew K. / Familial progressive supranuclear palsy : A literature review. In: Neurodegenerative Diseases. 2014 ; Vol. 13, No. 2-3. pp. 180-182.
@article{d98d66e5fcfd4638b85487d9f443455d,
title = "Familial progressive supranuclear palsy: A literature review",
abstract = "Background: Many genes/loci associated with Parkinsonian disorders have been identified. However, the genetic causes for a number of familial forms of Parkinsonian disorders remain to be elucidated. Objective: It was the aim of this paper to review the familial progressive supranuclear palsy (PSP) cases without any known gene mutations published in the English literature. Methods: We searched the PubMed database for reports of familial PSP cases without known mutations. Results: We found 19 PSP families. The mean age at onset was approximately 60 years, and the mean disease duration was about 8 years. Parkinsonism and ophthalmoplegia were most frequently reported, and a vast majority of patients manifested with these two symptoms. Other symptoms such as falls, postural instability and pyramidal signs were also common. A small subset of patients transiently responded to L-dopa therapy. Conclusion: There is an increasing number of reported familial PSP. A recently performed genome-wide association study indicated genetic factors for this condition. Furthermore, clinical, pathological and genetic investigations will open new avenues to the discovery of causative genes and new therapeutics for PSP.",
keywords = "Familial progressive supranuclear palsy, MAPT",
author = "Shinsuke Fujioka and {Van Gerpen}, {Jay A} and Uitti, {Ryan J.} and Dickson, {Dennis W} and Wszolek, {Zbigniew K}",
year = "2014",
month = "1",
doi = "10.1159/000354975",
language = "English (US)",
volume = "13",
pages = "180--182",
journal = "Neurodegenerative Diseases",
issn = "1660-2854",
publisher = "S. Karger AG",
number = "2-3",

}

TY - JOUR

T1 - Familial progressive supranuclear palsy

T2 - A literature review

AU - Fujioka, Shinsuke

AU - Van Gerpen, Jay A

AU - Uitti, Ryan J.

AU - Dickson, Dennis W

AU - Wszolek, Zbigniew K

PY - 2014/1

Y1 - 2014/1

N2 - Background: Many genes/loci associated with Parkinsonian disorders have been identified. However, the genetic causes for a number of familial forms of Parkinsonian disorders remain to be elucidated. Objective: It was the aim of this paper to review the familial progressive supranuclear palsy (PSP) cases without any known gene mutations published in the English literature. Methods: We searched the PubMed database for reports of familial PSP cases without known mutations. Results: We found 19 PSP families. The mean age at onset was approximately 60 years, and the mean disease duration was about 8 years. Parkinsonism and ophthalmoplegia were most frequently reported, and a vast majority of patients manifested with these two symptoms. Other symptoms such as falls, postural instability and pyramidal signs were also common. A small subset of patients transiently responded to L-dopa therapy. Conclusion: There is an increasing number of reported familial PSP. A recently performed genome-wide association study indicated genetic factors for this condition. Furthermore, clinical, pathological and genetic investigations will open new avenues to the discovery of causative genes and new therapeutics for PSP.

AB - Background: Many genes/loci associated with Parkinsonian disorders have been identified. However, the genetic causes for a number of familial forms of Parkinsonian disorders remain to be elucidated. Objective: It was the aim of this paper to review the familial progressive supranuclear palsy (PSP) cases without any known gene mutations published in the English literature. Methods: We searched the PubMed database for reports of familial PSP cases without known mutations. Results: We found 19 PSP families. The mean age at onset was approximately 60 years, and the mean disease duration was about 8 years. Parkinsonism and ophthalmoplegia were most frequently reported, and a vast majority of patients manifested with these two symptoms. Other symptoms such as falls, postural instability and pyramidal signs were also common. A small subset of patients transiently responded to L-dopa therapy. Conclusion: There is an increasing number of reported familial PSP. A recently performed genome-wide association study indicated genetic factors for this condition. Furthermore, clinical, pathological and genetic investigations will open new avenues to the discovery of causative genes and new therapeutics for PSP.

KW - Familial progressive supranuclear palsy

KW - MAPT

UR - http://www.scopus.com/inward/record.url?scp=84896872616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896872616&partnerID=8YFLogxK

U2 - 10.1159/000354975

DO - 10.1159/000354975

M3 - Article

C2 - 24080486

AN - SCOPUS:84896872616

VL - 13

SP - 180

EP - 182

JO - Neurodegenerative Diseases

JF - Neurodegenerative Diseases

SN - 1660-2854

IS - 2-3

ER -